Curie Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, among others. It provides services in the area such as genetics and carcinogenesis, cell and tissue imaging, and others. It offers care, research and training services for detecting, treating and monitoring cancer. Curie Institute provides services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain and medical imaging, among others. The foundation offers masters, PhD and postdoctoral fellowship programmes, and other courses. Curie Institute is headquartered in Paris, France.

Curie Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Curie Institute, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Licensing Agreements 25
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute – Key Competitors 31
Curie Institute – Key Employees 32
Curie Institute – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Strategy And Business Planning 34
Sep 17, 2018: Institut Curie announces creation of Honing Biosciences 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Curie Institute, Pharmaceuticals & Healthcare, Key Facts 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute, Key Competitors 31
Curie Institute, Key Employees 32

List of Figures
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Curie Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hutchison 3G UK Limited:企業の戦略・SWOT・財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報
    China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • ProAxsis Ltd:製品パイプライン分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sonic Healthcare Limited:企業の戦略・SWOT・財務情報
    Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report Summary Sonic Healthcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Solon Eiendom ASA (SOLON):企業の財務・戦略的SWOT分析
    Solon Eiendom ASA (SOLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Energizer Holdings, Inc.:企業の戦略・SWOT・財務情報
    Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nacco Industries Inc:企業の戦略・SWOT・財務情報
    Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Merge Healthcare Inc:医療機器:M&Aディール及び事業提携情報
    Summary Merge Healthcare Inc (Merge Technologies), a subsidiary of International Business Machines Corp, is a medical technology company that offers advanced solutions specifically designed for healthcare. The company's solutions include cardiology, orthopedics, interoperability, radiology, eye care …
  • Vanderbilt University Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center’s services include adult emergency services, case management, corporate health services, adult psychiat …
  • McAlister’s Corporation:企業の戦略・SWOT・財務情報
    McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report Summary McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chiesi USA Inc:企業の戦略的SWOT分析
    Chiesi USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Stagecoach Group plc (SGC):企業の財務・戦略的SWOT分析
    Stagecoach Group plc (SGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • Lenovo Group Ltd (992):企業の財務・戦略的SWOT分析
    Lenovo Group Ltd (992) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Heraeus Holding GmbH:企業の戦略・SWOT・財務情報
    Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sociedad Minera El Brocal SAA (BROCALC1):企業の財務・戦略的SWOT分析
    Sociedad Minera El Brocal SAA (BROCALC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Kingsgate Consolidated Limited:企業の戦略・SWOT・財務分析
    Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report Summary Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆